Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Polycystic Ovary Syndrome (PCOS) - 5-10% of women 50% lower glutathione levels compared to women without PCOS 3-4x higher risk of preeclampsia 3x higher risk of gestational diabetes Critical concern: With 50% lower baseline glutathione, the "safe" dose is effectively cut in half IVF Conception - 2-5% of births (up to 6-8% in some countries) Women who conceive via IVF experience dramatic antioxidant depletion: 70% reduction in plasma antioxidant capacity 83% reduction in follicular fluid antioxidant capacity 50-100%+ increase in oxidative stress markers With over 5 million babies born via IVF globally, this represents a large high-risk population Gallbladder Dysfunction - 10% of pregnant women Up to 10% develop gallstones or biliary sludge Intrahepatic cholestasis: 0.4-10% of pregnancies CRITICAL: Fatal Outcomes Documented at Therapeutic Doses The first case of a pregnant woman with intrahepatic cholestasis who died from liver failure after taking THERAPEUTIC/NORMAL doses of acetaminophen was reported in 2022
The insurance provider may approve continued treatment with Mounjaro if you have been on a stable maintenance dose of Mounjaro for at least 3 months and have achieved a reduction in A1C since starting treatment
Glutathione is a requirement for processing and removing all the bad stuff from your body, which includes environmental contaminants and substances in food
By improving HRV, L-carnitine helps shift the autonomic nervous system out of chronic sympathetic overdrive (the "fight or flight" state) and enhances parasympathetic vagal tone (the "rest and digest" state), promoting a calmer, more regulated nervous system response to physical stressors
Diabetes, Obesity & Metabolism
The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects
